An increased utilisation of chest x-ray (CXR) in general practice is associated with lung cancer diagnosis at an early stage and improved survival outcomes. Practices with the highest CXR rates are ...

Small cell lung cancer (SCLC) often responds well to initial treatment before later relapsing. Researchers are continuing to investigate new treatments, such as targeted therapy and immunotherapy ...

Records of more than 170,000 lung cancer patients combined with chest x-ray rates from 7,400 GP practices were analysed in the new research led by the University of Sheffield The study, published in ...

Exploring the role of posthumous organ donation attitudes: A comparative study of Egyptian cancer patients and healthy individuals. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I ...

Small cell lung cancer (SCLC) is rarer than non-small cell lung cancer (NSCLC) but tends to be more difficult to treat. SCLC can be more resistant and aggressive than other cancers, which can increase ...

Lung cancer is cancer that starts in your lungs. It is the leading cause of cancer death among men and women. Finding lung cancer early before it spreads improves your chances of beating the disease.

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer. Whether ...